Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Cergutuzumab Biosimilar - Anti-CEACAM5, CEA, CD66e mAb - Research Grade |
---|---|
Source | CAS 1509916-03-3 |
Species | Humanized |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Cergutuzumab,CEA-IL-2v,RG7813,RO-6895882,CEACAM5, CEA, CD66e,anti-CEACAM5, CEA, CD66e |
Reference | PX-TA1387 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IG-Gamma1 -[IL2 (interleukin 2, IL-2) 21-153, engineered]1_kappa |
Clonality | Monoclonal Antibody |
Cergutuzumab is investigated for the treatment of Advanced and/or Metastatic Solid Tumors.
Immobilized CD66e Recombinant Protein (cat. No.PX-P4089) at 0.5µg/mL (100µL/well) can bind to Cergutuzumab Biosimilar - Anti-CEACAM5, CEA, CD66e mAb (cat. No.PX-TA1387) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Reviews
Il n’y a pas encore d’avis.